#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Richter's syndrome Craniopharyngioma Autoimmune haemolytic anaemia Pleural mesothelioma Arterial disorder Anti-glomerular basement membrane disease Cryoglobulinaemia Acquired haemophilia Synovitis Univentricular heart Type IIa hyperlipidaemia Nephropathy Leiomyosarcoma recurrent Prolymphocytic leukaemia Fibrous dysplasia of bone More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Diagnostics Epidermolysis bullosa – Treatment Rhabdomyosarcoma recurrent – Treatment Hereditary motor and sensory neuropathy – Life with Disease Pemphigus – Trials in Disease Hairy cell leukaemia recurrent Chordoma – Basic Information Methylmalonic acidaemia – Basic Information Hepatic angiosarcoma – Treatment Short-bowel syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ripretinib Candesartan Cilexetil UDONITRECTAG Histidine Fedratinib Amifostine Thiol ARTICAINE HYDROCHLORIDE Efavirenz Finasteride Omalizumab GSKVX000000034794 Romiplostim Tabelecleucel Necvax-Neo1 ULIXERTINIB Linagliptin Heterodimeric Interleukin-15 Zilovertamab Vedotin Faricimab Emrusolmin More therapies…

    Learn about Your Condition

    Urticaria cholinergic Necrotising myositis Vertigo Cardiac disorder Diphtheria Malignant melanoma stage II Developmental hip dysplasia Cold type haemolytic anaemia Neuroendocrine carcinoma Inflammatory bowel disease Diminished ovarian reserve Pneumonia Cough Embolism venous Choroid melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn’s Disease After Inadequate Response to Other Treatments

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Obefazimod
    Belgium Czechia France Germany Hungary Italy +5

  • Study on Reducing Bleeding Risk in Fibroid Surgery Using Misoprostol for Patients Undergoing Myomectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Uterine leiomyoma
    Investigated Drugs:
    • Misoprostol
    • Placebo
    France

  • Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular seminoma (pure) stage I
    Investigated Drugs:
    • Bleomycin
    • Carboplatin
    • Cisplatin
    Norway Sweden

  • Study Comparing Oral Amoxicillin to Outpatient IV Antibiotics for Patients with Infective Endocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Investigated Drugs:
    • Amoxicillin
    Spain

  • Study on the Safety and Effectiveness of Inclisiran in Children Aged 2 to Under 12 with Homozygous Familial Hypercholesterolemia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Inclisiran
    Austria France Germany Greece The Netherlands Spain

  • Study on Oxytocin and Mindfulness Training for Reducing Stress in Adults with Psychological Distress

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Oxytocin
    Belgium
Previous Page
1 … 257 258 259 260 261 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!